Deep-Tech Bioengineering

120 nm magnetoelectric nanorobotics

Magnobot Med manufactures sub-micron robotic carriers guided by external 3D magnetic fields. Concentrated therapeutic payloads penetrate solid tumour stroma without systemic biological exposure.

Bench Validation

Measured nanoscale tolerances

120 nm

particle core diameter

< 0.4 mm

3D navigation accuracy

85%

toxicity reduction in vitro

Integrated System

Three-tier actuation hardware

3D Electromagnetic Navigation Array

Magnetoelectric Nanorobot Consumables

Custom multi-axis coil architecture generating calibrated magnetic field gradients for deep-tissue mechanical guidance through complex cellular barriers.

Engineered 120 nm carriers synthesized with biocompatible ferroelectric and ferromagnetic phases. Surface functionalization enables high-density oncological payload binding and on-demand magnetic triggering.

Spatiotemporal Trajectory Software

Algorithmic control module executing real-time field vector micro-adjustments to steer consumables directly into solid malignant stroma.

Engineering Axiom

Toxicity is a delivery failure

Current chemotherapeutics possess potent bioactivity against malignant cells, yet indiscriminate circulation damages vital organs. Active magnetic steering confines cytotoxic release exclusively to target lesions.

Preclinical data packages

Review cell-culture penetration metrics, microfluidic transport data, and translational protocols structured for institutional biopharma collaboration.